Cargando…
IgA-Dominant Glomerulopathy and Thrombotic Microangiopathy After Chemotherapy
Autores principales: | Dvanajscak, Zeljko, Karl, Bethany E., Sanchez, Amber P., Walavalkar, Vighnesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932117/ https://www.ncbi.nlm.nih.gov/pubmed/29725655 http://dx.doi.org/10.1016/j.ekir.2017.10.011 |
Ejemplares similares
-
Diagnostic Dilemma of Thrombotic Microangiopathy in Pregnancy
por: Kaartinen, Kati, et al.
Publicado: (2020) -
Drug-Induced Thrombotic Microangiopathy Resulting in ESRD
por: Agarwal, Krishna A., et al.
Publicado: (2020) -
Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge With Eculizumab
por: Efe, Orhan, et al.
Publicado: (2021) -
Kidney-Predominant Thrombotic Microangiopathy Associated With TREX1 Frameshift Mutation
por: Song, Zhuo-ran, et al.
Publicado: (2023) -
Kidney Thrombotic Microangiopathy After COVID-19 Associated With C3 Gene Mutation
por: Mat, Olivier, et al.
Publicado: (2021)